Product Overview
D-Cycloserine (CAS: 68-41-7) is a cyclic serine derivative and broad-spectrum antibiotic with the molecular formula C₃H₆N₂O₂ (MW: 102.09). It inhibits bacterial cell wall synthesis by competitively blocking D-alanine incorporation, making it critical for treating drug-resistant tuberculosis (TB) and urinary tract infections. Additionally, it acts as a partial NMDA receptor agonist, supporting neuroscience research in cognitive enhancement, PTSD, and anxiety disorders. This white crystalline powder is also used as a biochemical intermediate in enzyme studies.
✨ Key Advantages
✅ High Purity: ≥99% purity (HPLC/GC tested), ensuring reliability for pharmaceutical and research applications.
✅ Antibacterial Potency: Effective against multidrug-resistant Mycobacterium tuberculosis with MIC values of 10-20 µg/mL.
✅ Water Solubility: Soluble in water (50 mg/mL) and stable at melting point 155-156°C for flexible formulation.
🔬 Application Fields
Pharmaceuticals: First-line adjuvant for drug-resistant TB therapy and urinary tract infection treatment.
Neuroscience: NMDA receptor modulation for studies on memory enhancement and neuropsychiatric disorders.
Biochemical Synthesis: Key intermediate in peptidoglycan inhibitor development and enzymatic activity assays.
📜 Quality Assurance
Produced in GMP-certified facilities compliant with USP/EP standards.
Rigorous QC via HPLC, NMR, and mass spectrometry for batch consistency.
Complies with MSDS guidelines for safe handling, storage, and non-hazardous classification.
📈 Market Insights
The global anti-TB drug market is projected to reach $2.1B by 2030 (CAGR 5.7%), driven by rising multidrug-resistant TB cases. D-Cycloserine’s dual role in infectious disease and neuroscience research underscores its growing demand in pharmaceutical and academic sectors.


